Torsades de pointes and myocardial infarction following reversal of supraventricular tachycardia with adenosine: a case report.
Milena Ribeiro PaixãoFernando Faglioni RibasTarso Augusto Duenhas AccorsiKarine De Amicis LimaJosé Leão de SouzaPublished in: Einstein (Sao Paulo, Brazil) (2024)
Adenosine is an antiarrhythmic drug that slows conduction through the atrioventricular node and acts as a coronary blood vessel dilator. This case report highlights two unusual life-threatening events following the use of adenosine to revert supraventricular tachycardia in a structurally normal heart: non-sustained polymorphic ventricular tachycardia and myocardial infarction. A 46-year-old woman presented to the emergency department with a two-hour history of palpitations and was diagnosed with supraventricular tachycardia. Vagal maneuvers were ineffective, and after intravenous adenosine administration, the patient presented with chest pain and hypotension. The rhythm degenerated into non-sustained polymorphic ventricular tachycardia and spontaneously reverted to sinus rhythm with ST elevation in lead aVR and ST depression in the inferior and anterolateral leads. The patient spontaneously recovered within a few minutes. Despite successful arrhythmia reversal, the patient was admitted to the intensive care unit because of an infarction without obstructive atherosclerosis. This report aims to alert emergency physicians about the potential complications associated with supraventricular tachycardia and its reversal with adenosine.
Keyphrases
- catheter ablation
- atrial fibrillation
- case report
- emergency department
- heart failure
- protein kinase
- primary care
- left ventricular
- coronary artery disease
- healthcare
- cardiovascular disease
- coronary artery
- lymph node
- heart rate
- type diabetes
- risk assessment
- risk factors
- climate change
- low dose
- adverse drug
- transcatheter aortic valve replacement